D&A at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's D&A?
- Globus Medical (GMED) reported D&A of $29.53M in Q1 2026.
- How has Globus Medical's D&A changed year-over-year?
- Globus Medical's D&A decreased by 55.3% year-over-year, from $66.07M to $29.53M.
- What is the long-term trend for Globus Medical's D&A?
- Over 4 years (2021 to 2025), Globus Medical's D&A has grown at a 41.1% compound annual growth rate (CAGR), from $69.87M to $276.84M.
- What does D&A mean?
- The non-cash accounting expense for the aging of physical assets and the expiration of intangible assets.
- How do you interpret D&A?
- High levels may indicate significant capital investment in the past, while low levels may suggest aging infrastructure or lack of recent investment.
- How does D&A compare across companies?
- Highly dependent on the asset intensity of the business model and the company's history of acquisitions.